Orexigen Therapeutics Raises $30M

San Diego-based Orexigen Therapeutics said today that it has completed a $30M Series C funding. The firm said that the funding will be used to advance its clinical programs. Funding came from new investors MPM BioEquities and Wasatch Advisors, along with the firm's existing investors. Orexigen is developing treatments for obesity. The firm has now raised over $76M in funding. Prior investors in the firm include BA Venture Partners, Domain Associates, Kleiner Perkins Caufield and Byers, Montreux Equity Partners, Morgenthaler Ventures, and Sofinnova Ventures. More information »